Athyrium Capital Management LP 13D and 13G filings for Biora Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-08-27 4:22 pm Unchanged | 2021-08-24 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Capital Management LP | 184,170,513 47.000% | 0 (Unchanged) | Filing |
| 2021-06-21 4:32 pm Purchase | 2021-06-01 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Capital Management LP | 184,170,513 64.200% | 43,656,118 (+31.07%) | Filing |
| 2020-12-11 4:30 pm Purchase | 2020-12-07 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Capital Management LP | 140,514,395 67.100% | 82,256,030 (+141.19%) | Filing |
| 2020-07-06 4:29 pm Purchase | 2020-06-23 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Capital Management LP | 58,258,365 49.800% | 58,258,365 (New Position) | Filing |